Bamco Inc. NY Trims Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Bamco Inc. NY cut its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 6.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 750,000 shares of the company's stock after selling 50,000 shares during the quarter. Bamco Inc. NY owned approximately 0.86% of HealthEquity worth $61,388,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HQY. International Assets Investment Management LLC bought a new stake in shares of HealthEquity in the second quarter valued at approximately $35,000. Paladin Wealth LLC bought a new stake in shares of HealthEquity in the third quarter valued at approximately $39,000. GAMMA Investing LLC raised its position in shares of HealthEquity by 114.8% in the second quarter. GAMMA Investing LLC now owns 595 shares of the company's stock valued at $51,000 after purchasing an additional 318 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in HealthEquity during the second quarter valued at approximately $73,000. Finally, 1620 Investment Advisors Inc. purchased a new position in HealthEquity during the third quarter valued at approximately $112,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Price Performance

Shares of NASDAQ HQY traded up $0.12 during mid-day trading on Monday, reaching $101.66. The company's stock had a trading volume of 552,370 shares, compared to its average volume of 624,470. The firm has a market capitalization of $8.88 billion, a PE ratio of 84.62, a P/E/G ratio of 1.59 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The stock has a fifty day moving average of $90.16 and a two-hundred day moving average of $82.85. HealthEquity, Inc. has a 52 week low of $62.10 and a 52 week high of $105.82.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.16. The firm had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. As a group, sell-side analysts anticipate that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

HQY has been the subject of a number of research reports. Barrington Research upped their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research note on Monday. BTIG Research upped their price target on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a report on Thursday, November 14th. JMP Securities reiterated a "market outperform" rating and set a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Royal Bank of Canada reiterated an "outperform" rating and set a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Finally, The Goldman Sachs Group initiated coverage on shares of HealthEquity in a report on Friday, November 15th. They set a "neutral" rating and a $108.00 price target for the company. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, HealthEquity presently has a consensus rating of "Moderate Buy" and a consensus target price of $108.38.

Insider Buying and Selling at HealthEquity

In other news, Director Frank Corvino sold 1,039 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 10,536 shares of company stock worth $884,517 over the last ninety days. Company insiders own 2.20% of the company's stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.